ATX amplia therapeutics limited

News: ATX Amplia Therapeutics Says Approval From Korean Regulator

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Dec 4 (Reuters) - Amplia Therapeutics Ltd (ATX) :

    • APPROVAL FROM KOREAN REGULATOR TO INITIATE PHASE 2 ACCENT PANCREATIC CANCER TRIAL IN KOREA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
20.3¢
Change
0.018(9.46%)
Mkt cap ! $99.72M
Open High Low Value Volume
19.0¢ 20.5¢ 19.0¢ $744.9K 3.754M

Buyers (Bids)

No. Vol. Price($)
15 547407 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 297543 11
View Market Depth
Last trade - 14.32pm 08/08/2025 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.